Sol-Gel director reports 7,500 stock options

Sol-Gel Technologies Ltd. director Sharon Kochan reported existing derivative holdings in an initial ownership statement.

Rhea-AI Filing Summary

Sol-Gel Technologies Ltd. director Sharon Kochan reported existing derivative holdings in an initial ownership statement. The filing lists a stock option to buy 7,500 Ordinary Shares at an exercise price of $12.0000 per share, expiring on January 9, 2034.

The option vested as to 33.33% of the underlying Ordinary Shares on February 28, 2025 and is scheduled to vest in equal quarterly installments over the following two years, conditioned on continued service as a director. All 7,500 underlying shares are reported as directly held through this option position.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kochan Sharon

Role Director

Type	Security	Shares	Price	Value
holding	Stock Option (right to buy)	--	--	--

Holdings After Transaction: Stock Option (right to buy) — 7,500 contracts (Direct)

Footnotes (2)

1. F1. Ordinary shares, NIS 1.00 par value per share
2. F2. 2. The option vested as to 33.33% of the Ordinary Shares on February 28, 2025 and vests as to the remainder of the Ordinary Shares in equal quarterly installments over the following two years, subject to the Reporting Person's continued service as a director.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Sol-Gel Technologies (SLGL) director Sharon Kochan report on this Form 3?

Sharon Kochan reported existing stock option holdings as an initial ownership statement. The filing discloses a stock option over 7,500 Sol-Gel Ordinary Shares at an exercise price of $12.0000 per share, providing a clear snapshot of this director’s derivative position.

How many Sol-Gel Technologies (SLGL) shares are covered by Sharon Kochan’s option?

The option covers 7,500 underlying Ordinary Shares of Sol-Gel Technologies. These shares are tied to a single stock option award, giving the director the right to buy the shares at a fixed exercise price of $12.0000 per share before expiration.

What is the exercise price and expiration date of the Sol-Gel (SLGL) director’s option?

The stock option has a $12.0000 exercise price and expires on January 9, 2034. This long-dated option allows potential share purchases at that fixed price if exercised any time before the stated expiration date, subject to vesting and service conditions.

How does Sharon Kochan’s Sol-Gel (SLGL) option vest over time?

33.33% of the option vested on February 28, 2025, with the rest vesting quarterly over two years. Remaining portions vest in equal quarterly installments, provided Sharon Kochan continues serving as a director during this vesting period.

Is Sharon Kochan’s Sol-Gel (SLGL) Form 3 a buy or sell transaction?

The Form 3 does not report a new buy or sell transaction. It is an initial statement of beneficial ownership, listing an existing stock option over 7,500 Ordinary Shares rather than documenting open-market purchases or sales of Sol-Gel stock.

What type of security did Sol-Gel (SLGL) director Sharon Kochan report holding?

The filing reports a derivative security: a stock option (right to buy). This option relates to 7,500 underlying Sol-Gel Ordinary Shares, giving the director the right, but not the obligation, to purchase those shares at $12.0000 per share until January 9, 2034.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 03:01 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Kochan Sharon

(Last) (First) (Middle)

C/O SOL-GEL TECHNOLOGIES LTD.

7 GOLDA MEIR STREET

(Street)

NESS ZIONA 7403650

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Sol-Gel Technologies Ltd. [ SLGL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	(2)	01/09/2034	Ordinary Shares(1)	7,500	$12	D

Explanation of Responses:

1. Ordinary shares, NIS 1.00 par value per share

2. 2. The option vested as to 33.33% of the Ordinary Shares on February 28, 2025 and vests as to the remainder of the Ordinary Shares in equal quarterly installments over the following two years, subject to the Reporting Person's continued service as a director.

	/s/ Eyal Ben-Or, Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)